Kalobios Pharmaceuticals Inc (KBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KBIO | SLGL | MGX | ||
| Company | Kalobios Pharmaceuticals Inc | Sol-Gel Technologies Ltd | Metagenomi Therapeutics Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 1.6500 | 83.00 | 1.4600 | ||
| High | 2.2000 | 84.78 | 1.4650 | ||
| Low | 1.6200 | 80.00 | 1.4406 | ||
| Latest | 2.1900 | 79.30 | 1.4600 | ||
| Change | +0.4630 | -1.71 | -0.0100 | ||
| % Change | +26.81% | -2.11% | -0.68% | ||
| Volume | 29,900 | 3,689 | 14,582 | ||
| 20-Day Average Volume | 12,700 | 29,899 | 256,194 | ||
| Previous Close | 1.7270 | 81.01 | 1.4700 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.7043 | 66.16 | 1.5420 | ||
| 20-Day Raw Stochastic | 98.57% | 89.38% | 17.07% | ||
| 20-Day Relative Strength | 60.40 | 67.75 | 40.41 | ||
| Weighted Alpha | -53.96 | +652.04 | -44.20 | ||
| Today's Opinion | N/A | 100% Buy | 88% Sell | ||
| Previous Opinion | N/A | 100% Buy | 88% Sell | ||
| Last Month's Opinion | N/A | 100% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +36.88% since 07/28/17 | +22.39% since 02/11/26 | -3.95% since 02/11/26 | ||
| Low | 1.5700 on 08/02/17 | 62.08 on 02/13/26 | 1.4200 on 02/17/26 | ||
| High | 2.2000 on 08/04/17 | 84.78 on 02/19/26 | 1.5400 on 02/12/26 | ||
| 1-Month | |||||
| %Chg | +12.31% since 07/03/17 | +16.40% since 01/16/26 | -12.05% since 01/16/26 | ||
| Low | 1.5000 on 07/11/17 | 48.26 on 01/23/26 | 1.3900 on 02/06/26 | ||
| High | 2.2000 on 08/04/17 | 84.78 on 02/19/26 | 1.8000 on 01/23/26 | ||
| 3-Month | |||||
| %Chg | -5.60% since 05/04/17 | +124.47% since 11/19/25 | -9.32% since 11/19/25 | ||
| Low | 1.5000 on 07/11/17 | 34.10 on 11/20/25 | 1.3900 on 02/06/26 | ||
| High | 2.9500 on 05/17/17 | 84.78 on 02/19/26 | 1.8700 on 12/22/25 | ||
| 6-Month | |||||
| %Chg | -28.20% since 02/03/17 | +356.03% since 08/19/25 | -20.22% since 08/19/25 | ||
| Low | 1.5000 on 07/11/17 | 16.50 on 08/20/25 | 1.3900 on 02/06/26 | ||
| High | 3.2500 on 02/17/17 | 84.78 on 02/19/26 | 3.9500 on 10/16/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 32,806 | 225,677 | 55,194 | ||
| Shares Outstanding, K | 14,980 | 2,786 | 37,547 | ||
| Annual Sales | 0 | 11,540,000 | 52,300,000 | ||
| Annual Net Income | -27,010,000 | -10,580,000 | -78,060,000 | ||
| Last Quarter Sales | N/A | 400,000 | 8,660,000 | ||
| Last Quarter Net Income | N/A | -5,940,000 | -20,390,000 | ||
| 60-Month Beta | 2.99 | 1.36 | 0.50 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -2.13 on 11/20/25 | -0.55 on 11/11/25 | ||
| Latest Earnings Date | 09/22/17 | 05/05/26 | 03/16/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||